Skip to main content

Advertisement

Log in

Ferritin Levels and Hepcidin mRNA Expression in Peripheral Mononuclear Cells from Anemic Type 2 Diabetic Patients

  • Published:
Biological Trace Element Research Aims and scope Submit manuscript

Abstract

This study aims to measure iron nutrition parameters and to determine the presence of anemia in obese type 2 diabetic patients and to analyze the mRNA relative abundance of genes related to inflammation, immune system, iron metabolism, and mitochondrial activity. Obese type 2 diabetic (OBDM, n = 30) and healthy subjects (Cn, n = 30) were studied. Biochemical, anthropometric, and iron nutrition parameters were determined. Peripheral mononuclear cells from type 2 diabetic and control group were challenged with high concentrations of iron (Fe) and glucose and total mRNA was isolated. The frequency of anemia among diabetic patients was 4/30. OBDM patients with or without anemia had higher levels of ferritin and high-sensitivity C-reactive protein than the Cn group. mRNA relative abundance of nuclear factor kappa-light-chain-enhancer of activated B cells was elevated in OBDM with anemia, and mRNA expression of interleukin-6 and toll-like receptor (TLR) 2 was increased in OBDM group in basal high Fe and high glucose concentrations. The expression of tumor necrosis factor alpha and TLR-4 was increased in OBDM with anemia in all experimental conditions. Hepcidin mRNA expression was increased in OBDM with anemia even in basal Fe concentration, and mitofusin 2 was decreased in all experimental conditions. This study shows that obese type 2 diabetic patients have iron distribution disorders associated to their proinflammatory state, and anemic subjects have a marked elevation of hepcidin mRNA expression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Jiang H, Sun Z, Tang YT, Xu C, Jiao XY (2011) Hepcidin expression and iron parameters change in type-2 diabetic patients. Diab Res Clin Prac 93:43–48

    Article  CAS  Google Scholar 

  2. Fernandez-Real JM, Lopez-Bermejo A, Ricart W (2002) Cross-talk between iron metabolism and diabetes. Diabetes 51:2348–2354

    Article  PubMed  CAS  Google Scholar 

  3. Sun L, Franco OH, Hu FB, Cai L, Yu Z, Li H (2008) Ferritin concentrations, metabolic syndrome, and type 2 diabetes in middle-aged and elderly Chinese. J Clin Endocrinol Metab 93:4690–4696

    Article  PubMed  CAS  Google Scholar 

  4. You SA, Wang Q (2005) Ferritin in atherosclerosis. Clin Chim Acta 357:1–16

    Article  PubMed  CAS  Google Scholar 

  5. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T (2003) Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101:2461–2463

    Article  PubMed  CAS  Google Scholar 

  6. Ganz T, Nemeth E (2011) Hepcidin and disorders in iron metabolism. Annu Rev Med 62:347–360

    Article  PubMed  CAS  Google Scholar 

  7. Shi H, Kokoeva M, Inouye K, Tzameli I, Yin H, Flier J (2006) TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116:3015–3025

    Article  PubMed  CAS  Google Scholar 

  8. Bach D, Naon D, Pich S, Soriano FX, Vega N, Rieusset J (2005) Expression of Mfn2, the Charcot-Marie-Tooth neuropathy type 2A gene, in human skeletal muscle: effects of type 2 diabetes, obesity, weight loss, and the regulatory role of tumor necrosis factor alpha and interleukin-6. Diabetes 54:2685–2693

    Article  PubMed  CAS  Google Scholar 

  9. Cook JD, Flowers CH, Skikne BS (2003) The quantitative assessment of body iron. Blood 101:3359–3364

    Article  PubMed  CAS  Google Scholar 

  10. Forouhi NG, Harding AH, Allison M, Sandhu MS, Welch A, Luben R (2007) Elevated serum ferritin levels predict new onset type 2 diabetes: results from the EPIC-Norfolk prospective study. Diabetologia 50:949–956

    Article  PubMed  CAS  Google Scholar 

  11. Bekri S, Gual P, Anty R, Luciani N, Dahman M, Ramesh B, Iannelli A, Staccini-Myx A, Casanoca D, Ben Amor I, Saint-Paul MC, Huet PM, Sadoul JL, Gugenheim J, Kaila S, Tran A, Marchand-Brustel YL (2006) Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology 131:788–796

    Article  PubMed  CAS  Google Scholar 

  12. Kovács F, Szakál I, Révész K, Lévai A, Dobos A (2006) Anemia and iron metabolism in patients with type-2 diabetes mellitus. Orv Hetil 147:345–349

    PubMed  Google Scholar 

  13. Dasu MR, Devaraj S, Zhao L, Hwang DH, Jialal I (2008) High glucose induces toll-like receptor expression in human monocytes: mechanism of activation. Diabetes 57:3090–3098

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This research was supported by grants from the Chilean Diabetes and Endocrinology Society (SOCHED) and FONDECYT with numbers 1085173 and 1110080.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Andrews.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Andrews, M., Arredondo, M. Ferritin Levels and Hepcidin mRNA Expression in Peripheral Mononuclear Cells from Anemic Type 2 Diabetic Patients. Biol Trace Elem Res 149, 1–4 (2012). https://doi.org/10.1007/s12011-012-9389-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12011-012-9389-6

Keywords

Navigation